UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink.
“I am delighted to welcome Bruno to the Olink organization, and look forward to the value his considerable industry experience will add to our rapidly growing company.” said Carl Raimond, President of Olink. “Over the past two years, Olink has experienced remarkable growth. We have a deep and talented executive team that is well positioned to drive growth and sustain market leadership in the next generation proteomics industry.”
Bruno Rossi brings more than 25 years of global experience in the life sciences industry, including the laboratory, pharmaceutical, and diagnostic market segments; and with senior strategic roles in product management, sales and marketing, and R&D. Before joining Olink, Bruno held multiple leadership positions at Leica Microsystems (a Danaher company) most recently serving as Vice President Global Business Transformation. Previous to Leica Microsystems, Bruno spent 22 years at Millipore (now part of Merck KGaA) holding various senior positions in sales, marketing, and product management. Bruno holds a Master’s degree in Organic Chemistry from École Nationale Supérieure de Chimie de Clermont-Ferrand (ENSCCF).
“With its best-in-class technology, leading commercial organization, and tremendous talent, Olink has positioned itself as a major force within the next-generation proteomics market,” said Bruno Rossi, CCO of Olink. “It’s with great excitement that I join the Company to help drive our next phase of growth, and I look forward to working with the entire organization to achieve our commercial goals.”